Marco Chacón
Nessuna posizione attualmente
Posizioni attive di Marco Chacón
Società | Posizione | Inizio | Fine |
---|---|---|---|
University of Maryland | Direttore/Membro del Consiglio | 01/01/2014 | - |
Havencrest Capital Management LLC
Havencrest Capital Management LLC Investment ManagersFinance Havencrest Capital Management LLC (Havencrest Capital) is a private equity firm founded in 2017 by Christopher W. Kersey. The firm is headquartered in Dallas, Texas. | Investitore di Private Equity | - | - |
Center For Breakthrough Medicines Holdings LLC
Center For Breakthrough Medicines Holdings LLC Miscellaneous Commercial ServicesCommercial Services Center For Breakthrough Medicines Holdings LLC is a private company that specializes in gene and cell therapy. The company is based in King of Prussia, PA. The company offers innovative services that are saving lives. The company was founded by Audrey E. Greenberg. | Presidente | 01/01/2020 | - |
Storia della carriera di Marco Chacón
Precedenti posizioni note di Marco Chacón
Società | Posizione | Inizio | Fine |
---|---|---|---|
Catalent Maryland, Inc.
Catalent Maryland, Inc. BiotechnologyHealth Technology Catalent Maryland, Inc. engages in the manufactures of biopharmaceuticals products such as viral vectors, vaccines, and proteins and oncolytic viruses. It offers process development, GMP manufacturing, fill and finish, analytical development, master and working cell and virus banks, quality systems, and stabilities studies services. The company was founded by Marco A. Chacon in 1990 and is headquartered in Baltimore, MD. | Direttore/Membro del Consiglio | 01/01/1990 | 26/01/2016 |
Amministratore Delegato | 05/01/2011 | - | |
Presidente | - | 01/02/2017 | |
Fondatore | 01/01/1990 | 01/02/2017 | |
Presidente | 05/01/2011 | - | |
Greater Baltimore Technology Council, Inc. | Direttore/Membro del Consiglio | - | - |
Psyadon Pharmaceuticals, Inc.
Psyadon Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Psyadon Pharmaceuticals, Inc. specializes in the development of drugs for central nervous system diseases. Its ecopipam product is an antagonist of the d1 dopamine receptor that blocks the actions of the neurotransmitter dopamine at the d1 receptor-family in the brain. The firm focuses its efforts on drugs for orphan indications because of the high medical need for effective treatments in these areas. The company was founded by Jeffrey D. Rothstein and David S. Block in 2004 and is headquartered in Germantown, MD. | Amministratore Delegato | - | - |
Presidente | 19/07/2011 | - | |
Tech Council of Maryland, Inc.
Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Tech Council of Maryland, Inc. provides membership association services for technology and life science communities. The firm serves the advanced technology and biotechnology communities. The company was founded in 1986 and is headquartered in Rockville, MD. | Direttore/Membro del Consiglio | 19/05/2010 | - |
Formazione di Marco Chacón
Youngstown State University | Undergraduate Degree |
University of Maryland | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Posizioni
Director/Board Member | 4 |
President | 3 |
Chief Executive Officer | 2 |
Settori
Commercial Services | 4 |
Consumer Services | 3 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 6 |
---|---|
Tech Council of Maryland, Inc.
Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Tech Council of Maryland, Inc. provides membership association services for technology and life science communities. The firm serves the advanced technology and biotechnology communities. The company was founded in 1986 and is headquartered in Rockville, MD. | Commercial Services |
Catalent Maryland, Inc.
Catalent Maryland, Inc. BiotechnologyHealth Technology Catalent Maryland, Inc. engages in the manufactures of biopharmaceuticals products such as viral vectors, vaccines, and proteins and oncolytic viruses. It offers process development, GMP manufacturing, fill and finish, analytical development, master and working cell and virus banks, quality systems, and stabilities studies services. The company was founded by Marco A. Chacon in 1990 and is headquartered in Baltimore, MD. | Health Technology |
Psyadon Pharmaceuticals, Inc.
Psyadon Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Psyadon Pharmaceuticals, Inc. specializes in the development of drugs for central nervous system diseases. Its ecopipam product is an antagonist of the d1 dopamine receptor that blocks the actions of the neurotransmitter dopamine at the d1 receptor-family in the brain. The firm focuses its efforts on drugs for orphan indications because of the high medical need for effective treatments in these areas. The company was founded by Jeffrey D. Rothstein and David S. Block in 2004 and is headquartered in Germantown, MD. | Retail Trade |
Greater Baltimore Technology Council, Inc. | Commercial Services |
Havencrest Capital Management LLC
Havencrest Capital Management LLC Investment ManagersFinance Havencrest Capital Management LLC (Havencrest Capital) is a private equity firm founded in 2017 by Christopher W. Kersey. The firm is headquartered in Dallas, Texas. | Finance |
Center For Breakthrough Medicines Holdings LLC
Center For Breakthrough Medicines Holdings LLC Miscellaneous Commercial ServicesCommercial Services Center For Breakthrough Medicines Holdings LLC is a private company that specializes in gene and cell therapy. The company is based in King of Prussia, PA. The company offers innovative services that are saving lives. The company was founded by Audrey E. Greenberg. | Commercial Services |
- Borsa valori
- Insiders
- Marco Chacón
- Esperienza